-
1001
Transdermal delivery of PeptiCRAd cancer vaccine using microneedle patches
Published 2025-03-01“…Microneedles (MNs) are a prospective system in cancer immunotherapy to overcome barriers regarding proper antigen delivery and presentation. …”
Get full text
Article -
1002
-
1003
Rationale and design of a multicentre randomised controlled trial on circulating tumour DNA-guided neoadjuvant treatment strategy for locally advanced rectal cancer (CINTS-R)
Published 2025-02-01“…New strategies such as total neoadjuvant therapy (TNT) and neoadjuvant immunotherapy have shown great promise in certain patient populations. …”
Get full text
Article -
1004
Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
Published 2011-01-01“…Following allogeneic stem cell transplantation, awareness for atypical manifestations of granulocytic sarcoma appears prudent, the cellular immunotherapy should aim at immunological disease control.…”
Get full text
Article -
1005
Metastatic Malignant Melanoma of the Inguinal Lymph Node with Unknown Primary Lesion
Published 2015-01-01“…Work up could not detect the primary lesion and patient was started on radiotherapy and immunotherapy. Conclusion. We present a case of malignant melanoma of unknown primary presenting in an unusual place which is the inguinal lymph node. …”
Get full text
Article -
1006
Fluorescence-Guided Resection of Malignant Glioma with 5-ALA
Published 2016-01-01“…In the future, chemotherapy with new anticancer agents, immunotherapy, and new methods of radiotherapy and gene therapy will be developed; however, ALA will play a key role in malignant glioma treatment before the development of these new treatments. …”
Get full text
Article -
1007
Central Precocious Puberty as a Complication of Therapy with Adrenocorticotropin (ACTH) and an Aromatase Inhibitor for Refractory Nephrotic Syndrome
Published 2019-01-01“…We report a 6 8/12-year-old girl with recurrent proteinuria, resistant to standard immunotherapy. She underwent related renal transplant but again developed proteinuria and was started on ACTH. …”
Get full text
Article -
1008
Potential of Black Phosphorus in Immune-Based Therapeutic Strategies
Published 2022-01-01“…In conclusion, BP shows promise in natural antitumor biological activity, biological imaging, drug delivery, PTT/PDT/SDT/PAT/PIT, nanovaccines, nanoadjuvants, and combination immunotherapy regimens.…”
Get full text
Article -
1009
Protein Kinases and Their Inhibitors in Pluripotent Stem Cell Fate Regulation
Published 2019-01-01Get full text
Article -
1010
Role of Interferons in the Development of Diagnostics, Vaccines, and Therapy for Tuberculosis
Published 2017-01-01“…This review summarizes the main aspects related with the biology of IFNs, mainly associated with TB, as well as presents the main applications of these cytokines related to prophylaxis, diagnosis, and immunotherapy of TB.…”
Get full text
Article -
1011
Recognition and Treatment of BCG Failure in Bladder Cancer
Published 2011-01-01“…In this setting, treatment options are limited and include repeat BCG treatment, an alternate immunotherapy regimen, chemotherapy, or device-assisted therapy. …”
Get full text
Article -
1012
Induction of Tolerance via the Sublingual Route: Mechanisms and Applications
Published 2012-01-01“…The clinical efficacy of sublingual immunotherapy (SLIT) with natural allergen extracts has been established in IgE-dependent respiratory allergies to grass or tree pollens, as well as house dust mites. …”
Get full text
Article -
1013
Maxillary osteonecrosis linked to Pembrolizumab therapy: a case report
Published 2024-01-01“…Conclusion: While definitive causality between Pembrolizumab and osteonecrosis of the jaw cannot be established with the current evidence, this case adds to the growing body of literature suggesting that immune checkpoint inhibitors may be implicated in the pathogenesis of osteonecrosis of the jaw. As the use of immunotherapy expands in oncology, further research is essential to elucidate this association and provide guidelines.…”
Get full text
Article -
1014
ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives
Published 2019-01-01“…PR3-derived PR1 peptide is being studied as an immunotherapy target in leukemia and multiple myeloma. …”
Get full text
Article -
1015
Ocular Melanoma Metastasizing to Intra-Abdominal Lymph Nodes
Published 2013-01-01Get full text
Article -
1016
DNA Vaccination: Using the Patient's Immune System to Overcome Cancer
Published 2010-01-01“…Along this line, the development of immunotherapy in general and the innovative concept of DNA vaccination in particular may provide a venue to achieve this goal. …”
Get full text
Article -
1017
-
1018
Latest Approved Therapies for Metastatic Melanoma: What Comes Next?
Published 2013-01-01“…Nowadays, oncogene-directed therapy and immunotherapy represent the two most promising avenues for patients with metastatic melanoma. …”
Get full text
Article -
1019
DRG2 as a Biomarker to Enhance the Predictive Efficacy of PD-L1 Immunohistochemistry Assays
Published 2024-12-01“…PD-L1 immunohistochemistry (IHC) assays are used as a companion diagnostic for immunotherapy with immune checkpoint inhibitors (ICIs). …”
Get full text
Article -
1020
Hodgkin Lymphoma Mimicking Inflammatory Breast Carcinoma: A Rare Case with Diagnostic Challenge and Novel Treatment
Published 2019-01-01“…It is also the first report highlighting the importance of this novel immunotherapy in the management of refractory Hodgkin lymphoma with breast involvement.…”
Get full text
Article